Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial

NCT02198248 is registered in ClinicalTrials.gov with Chiba University as lead sponsor.

NCT NCT02198248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02198248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Lead sponsor
Chiba University
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2014
Completion date
June 30, 2021
Enrollment
140 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

anti-neutrophil cytoplasmic antibody-associated vasculitis, microscopic polyangiitis, wegener granulomatosis